ENTPD1 and Sepsis: For example, previous studies have shown that, towards the end of the early hyperinflammatory phase of sepsis, the P2X7 receptor competes with several ectoenzymes, such as CD39, which is produced in monocytes and scavenges extracellular ATP, contributing to the reduction of P2X7 receptor activity (40, 41).